United States · FDA National Drug Code directory
adenosine
A source-listed medicine record.
Factual source checks only. This page is not a clinically reviewed monograph. Historical or discontinued records may be included; listing does not confirm approval, current availability or pharmacy stock.
Medicine identity
- Source reference
- 25021-301_a40e7fe9-478d-4916-9657-5eba074215f0
- Product NDC
- 25021-301
- Form
- INJECTION
- Composition / generic term
- adenosine
- Labeler
- Sagent Pharmaceuticals
- Marketing category
- ANDA
- Marketing start / end (source format)
- 20140416
- Source listing expiry
- 20261231
Source-listed ingredients
- ADENOSINE — 3 mg/mL
These values do not establish equivalence or a dose recommendation.
Packages
- 10 SYRINGE in 1 CARTON (25021-301-67) / 2 mL in 1 SYRINGE · 25021-301-67
- 10 SYRINGE in 1 CARTON (25021-301-68) / 4 mL in 1 SYRINGE · 25021-301-68
Source and coverage
Open FDA National Drug Code directory →
Snapshot retrieved: 2026-09-17. This is the acquisition date, not a medical review date.
Clinical information, images and comparisons appear only when separately reviewed for this record. Coverage may be incomplete. Ask a pharmacist or clinician about your treatment.
Browse United States records →